VVA
Vida Ventures Advisors Portfolio holdings
AUM
$15.9M
This Quarter Return
-12.06%
1 Year Return
+52.49%
3 Year Return
+45.65%
5 Year Return
-49.37%
10 Year Return
–
AUM
$64.6M
AUM Growth
+$64.6M
(-16%)
Cap. Flow
+$975K
Cap. Flow
% of AUM
1.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$975K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $25.4M | 39.38% | 3,931,818 | – | – |
|
2
Dyne Therapeutics
DYN
$1.92B
| $19.9M | 30.79% | 2,220,034 | – | – |
|
3
Allogene Therapeutics
ALLO
$251M
| $5.7M | 8.82% | 1,798,163 | – | – |
|
|
KRON
4
DELISTED
Kronos Bio
KRON
| $3.59M | 5.56% | 2,765,314 | – | – |
|
|
LIAN
5
DELISTED
LianBio American Depositary Shares
LIAN
| $3.4M | 5.26% | 2,282,084 | – | – |
|
|
KNTE
6
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.09M | 4.78% | 2,207,772 | – | – |
|
7
Praxis Precision Medicines
PRAX
$958M
| $2.51M | 3.89% | 1,469,665 | – | – |
|
|
IMA
8
ImageneBio, Inc. Common Stock
IMA
$150M
| $975K | 1.51% | +225,192 | New | +$975K |
|